Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 05-02-2018 | Practice Area: | Corporate and M&A |
| Deal Title: | Sanofi Definitive Agreement for Acquisition of Ablynx | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Sanofi and Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies, entered into a definitive agreement under which Sanofi offered to acquire all of the outstanding ordinary shares, which represented an aggregate equity value of approximately EUR3.9 billion. Linklaters advised Ablynx on the deal.
|
||
| Financial Center: | Brussels | Value: | 1000.01-5000.00 |
| Advised Party: | Target Company | Law Firm | Linklaters |
| Target Company Jurisdiction: | Belgium | Acquiror Jurisdiction: | Belgium |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | Arnaud Coibion |
